{"id":"https://openalex.org/W7225423882","doi":"https://doi.org/10.12890/2026_007474","title":"Diagnostically challenging Pro-B ALL followed by emergence of monocytic AML after successful CAR-T treatment","display_name":"Diagnostically challenging Pro-B ALL followed by emergence of monocytic AML after successful CAR-T treatment","publication_year":2026,"publication_date":"2026-11-06","ids":{"openalex":"https://openalex.org/W7225423882","doi":"https://doi.org/10.12890/2026_007474"},"language":"en","primary_location":{"id":"doi:10.12890/2026_007474","doi":"https://doi.org/10.12890/2026_007474","is_oa":true,"landing_page_url":"https://doi.org/10.12890/2026_007474","pdf_url":"https://ejcrim.com/index.php/ejcrim/article/download/7474/6076","source":{"id":"https://openalex.org/S2737828108","display_name":"European Journal of Case Reports in Internal Medicine","issn_l":"2284-2594","issn":["2284-2594"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310317697","host_organization_name":"SMC MEDIA SRL","host_organization_lineage":["https://openalex.org/P4310317697"],"host_organization_lineage_names":["SMC MEDIA SRL"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Case Reports in Internal Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://ejcrim.com/index.php/ejcrim/article/download/7474/6076","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028232490","display_name":"Chen Glait Santar","orcid":"https://orcid.org/0009-0002-0666-496X","observed_orcids":["https://orcid.org/0009-0002-0666-496X"]},"institutions":[{"id":"https://openalex.org/I2799807261","display_name":"Tel Aviv Sourasky Medical Center","ror":"https://ror.org/04nd58p63","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799807261"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Chen Glait Santar","raw_affiliation_strings":["The Cellular Immunophenotyping Unit, Hematology Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Cellular Immunophenotyping Unit, Hematology Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel","institution_ids":["https://openalex.org/I2799807261"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042161976","display_name":"Ben\u2010Zion Katz","orcid":"https://orcid.org/0000-0001-5058-943X","observed_orcids":["https://orcid.org/0000-0001-5058-943X"]},"institutions":[{"id":"https://openalex.org/I16391192","display_name":"Tel Aviv University","ror":"https://ror.org/04mhzgx49","country_code":"IL","type":"education","lineage":["https://openalex.org/I16391192"]},{"id":"https://openalex.org/I2799807261","display_name":"Tel Aviv Sourasky Medical Center","ror":"https://ror.org/04nd58p63","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799807261"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Ben-Zion Katz","raw_affiliation_strings":["Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel","The Cellular Immunophenotyping Unit, Hematology Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel","institution_ids":["https://openalex.org/I16391192"]},{"raw_affiliation_string":"The Cellular Immunophenotyping Unit, Hematology Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel","institution_ids":["https://openalex.org/I2799807261"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":300,"currency":"EUR","value_usd":323},"apc_paid":{"value":300,"currency":"EUR","value_usd":323},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.8393999934196472,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.8393999934196472,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.08269999921321869,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.051100000739097595,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/therapy-related-acute-myeloid-leukemia","display_name":"therapy-related acute myeloid leukemia","score":0.902999997138977},{"id":"https://openalex.org/keywords/monocytic-aml","display_name":"monocytic AML","score":0.8220000267028809},{"id":"https://openalex.org/keywords/cd19-car-t-cell-therapy","display_name":"CD19 CAR T-cell therapy","score":0.9039999842643738},{"id":"https://openalex.org/keywords/clonal-evolution","display_name":"clonal evolution","score":0.871999979019165},{"id":"https://openalex.org/keywords/lineage-plasticity","display_name":"lineage plasticity","score":0.9860000014305115},{"id":"https://openalex.org/keywords/immunophenotyping","display_name":"immunophenotyping","score":0.8960000276565552},{"id":"https://openalex.org/keywords/inotuzumab-ozogamicin","display_name":"inotuzumab ozogamicin","score":0.8650000095367432},{"id":"https://openalex.org/keywords/hyperdiploidy","display_name":"hyperdiploidy","score":0.7400000095367432},{"id":"https://openalex.org/keywords/philadelphia-chromosome-negative-all","display_name":"Philadelphia chromosome-negative ALL","score":0.7350000143051147}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8992999792098999},{"id":"https://openalex.org/C196166836","wikidata":"https://www.wikidata.org/wiki/Q902926","display_name":"Immunophenotyping","level":3,"score":0.7797999978065491},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5453000068664551},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.4982999861240387},{"id":"https://openalex.org/C2778623314","wikidata":"https://www.wikidata.org/wiki/Q412685","display_name":"Gemtuzumab ozogamicin","level":5,"score":0.47999998927116394},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4650999903678894},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4440000057220459},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4341999888420105},{"id":"https://openalex.org/C176290653","wikidata":"https://www.wikidata.org/wiki/Q21114013","display_name":"CD33","level":4,"score":0.426800012588501},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.4180000126361847},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.41280001401901245},{"id":"https://openalex.org/C81182388","wikidata":"https://www.wikidata.org/wiki/Q353963","display_name":"Complication","level":2,"score":0.39899998903274536},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.3817000091075897},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.37439998984336853},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3716999888420105},{"id":"https://openalex.org/C2780943621","wikidata":"https://www.wikidata.org/wiki/Q1313618","display_name":"Monocytic leukemia","level":3,"score":0.35429999232292175},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34950000047683716},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.31610000133514404},{"id":"https://openalex.org/C2776817793","wikidata":"https://www.wikidata.org/wiki/Q6553369","display_name":"Lineage (genetic)","level":3,"score":0.3091999888420105},{"id":"https://openalex.org/C2776863199","wikidata":"https://www.wikidata.org/wiki/Q976388","display_name":"Acute leukemia","level":3,"score":0.30570000410079956},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.30469998717308044},{"id":"https://openalex.org/C2776611710","wikidata":"https://www.wikidata.org/wiki/Q16888295","display_name":"Induction chemotherapy","level":3,"score":0.3034999966621399},{"id":"https://openalex.org/C3018657049","wikidata":"https://www.wikidata.org/wiki/Q1595418","display_name":"Complete remission","level":3,"score":0.2978000044822693},{"id":"https://openalex.org/C2781107101","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Acute lymphocytic leukemia","level":4,"score":0.2971000075340271},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.2955000102519989},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.28940001130104065},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.2782999873161316},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.2736000120639801},{"id":"https://openalex.org/C2779788671","wikidata":"https://www.wikidata.org/wiki/Q998803","display_name":"Tumor lysis syndrome","level":3,"score":0.27239999175071716}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.12890/2026_007474","doi":"https://doi.org/10.12890/2026_007474","is_oa":true,"landing_page_url":"https://doi.org/10.12890/2026_007474","pdf_url":"https://ejcrim.com/index.php/ejcrim/article/download/7474/6076","source":{"id":"https://openalex.org/S2737828108","display_name":"European Journal of Case Reports in Internal Medicine","issn_l":"2284-2594","issn":["2284-2594"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310317697","host_organization_name":"SMC MEDIA SRL","host_organization_lineage":["https://openalex.org/P4310317697"],"host_organization_lineage_names":["SMC MEDIA SRL"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Case Reports in Internal Medicine","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.12890/2026_007474","doi":"https://doi.org/10.12890/2026_007474","is_oa":true,"landing_page_url":"https://doi.org/10.12890/2026_007474","pdf_url":"https://ejcrim.com/index.php/ejcrim/article/download/7474/6076","source":{"id":"https://openalex.org/S2737828108","display_name":"European Journal of Case Reports in Internal Medicine","issn_l":"2284-2594","issn":["2284-2594"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310317697","host_organization_name":"SMC MEDIA SRL","host_organization_lineage":["https://openalex.org/P4310317697"],"host_organization_lineage_names":["SMC MEDIA SRL"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Case Reports in Internal Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225423882.pdf","grobid_xml":"https://content.openalex.org/works/W7225423882.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W2073583182","https://openalex.org/W2168990131","https://openalex.org/W4385515995","https://openalex.org/W4402700670","https://openalex.org/W4403326582","https://openalex.org/W4405108495","https://openalex.org/W4405317249","https://openalex.org/W4409994712","https://openalex.org/W4412820351","https://openalex.org/W7136082913"],"related_works":["https://openalex.org/W7203493714","https://openalex.org/W3108772849","https://openalex.org/W4392295265","https://openalex.org/W7168289022","https://openalex.org/W2149723234","https://openalex.org/W2324942737","https://openalex.org/W4380576277","https://openalex.org/W4296468318","https://openalex.org/W2469611221","https://openalex.org/W3049412143"],"abstract_inverted_index":{"Introduction:":[0],"Therapy-related":[1],"acute":[2,34,157],"myeloid":[3,179],"leukemia":[4,36],"(t-AML)":[5],"is":[6],"a":[7,53,68],"recognized":[8],"complication":[9],"of":[10,17,74,141,150,177],"leukemia-directed":[11],"cytotoxic":[12],"therapy.":[13,183],"However,":[14],"the":[15,88,99,148,161,175],"emergence":[16,176],"therapy-related":[18],"monocytic":[19,135],"AML":[20,136],"shortly":[21],"after":[22,181],"successful":[23],"CD19-directed":[24,123],"chimeric":[25],"antigen":[26],"receptor":[27],"T-cell":[28],"(CAR-T)":[29],"therapy":[30],"for":[31],"relapsed":[32],"Pro-B":[33,60,91],"lymphoblastic":[35],"(B-ALL)":[37],"raises":[38],"important":[39],"questions":[40],"regarding":[41],"clonal":[42],"evolution,":[43],"lineage":[44],"plasticity,":[45],"and":[46,76,106,159,170],"treatment-related":[47,107],"leukemogenesis.":[48],"Case":[49],"Description:":[50],"We":[51],"describe":[52],"73-year-old":[54],"man":[55],"diagnosed":[56],"with":[57,62,98,118,137],"Philadelphia":[58],"chromosome-negative":[59],"ALL":[61],"hyperdiploidy/tetraploidy,":[63],"whose":[64],"initial":[65],"presentation":[66],"posed":[67],"diagnostic":[69],"challenge":[70],"due":[71],"to":[72],"expression":[73],"immature":[75],"partial":[77],"myeloid-associated":[78],"markers,":[79],"initially":[80],"suggesting":[81],"minimally":[82],"differentiated":[83],"AML.":[84],"Repeat":[85],"immunophenotyping":[86],"clarified":[87],"diagnosis":[89],"as":[90],"ALL.":[92],"The":[93],"patient":[94],"achieved":[95],"complete":[96],"remission":[97],"GMALL":[100],"Elderly":[101],"protocol":[102],"despite":[103],"severe":[104],"infectious":[105],"complications.":[108],"Following":[109],"relapse":[110],"during":[111],"maintenance":[112],"therapy,":[113,125],"he":[114,132],"received":[115],"salvage":[116],"treatment":[117],"inotuzumab":[119],"ozogamicin":[120],"followed":[121],"by":[122],"CAR-T":[124,182],"achieving":[126],"marrow":[127],"remission.":[128],"Five":[129],"months":[130],"later,":[131],"developed":[133],"secondary":[134,178],"no":[138],"immunophenotypic":[139,152],"evidence":[140],"residual":[142],"B-ALL.":[143],"Conclusion:":[144],"This":[145],"case":[146],"underscores":[147],"importance":[149],"precise":[151],"characterization":[153],"in":[154],"diagnostically":[155],"ambiguous":[156],"leukemias":[158],"illustrates":[160],"complex":[162],"biologic":[163],"evolution":[164],"that":[165],"may":[166],"follow":[167],"sequential":[168],"chemotherapy":[169],"modern":[171],"immunotherapeutic":[172],"approaches,":[173],"including":[174],"neoplasms":[180]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-07T00:00:00"}